ctrl K

AI Score

Unlock

Acumen Pharmaceuticals In... (ABOS)

AI Score

Unlock

1.16

-0.12 (-9.38%)

At close: Mar 03, 2025, 3:59 PM

1.15

-0.86%

After-hours: Mar 03, 2025, 04:00 PM EST

Acumen Pharmaceuticals Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19
Cash & Equivalents	66.89M	130.1M	122.16M	43.78M	6.55M
Short-Term Investments	176.64M	47.5M	72.08M	n/a	n/a
Long-Term Investments	62.55M	15.84M	31.62M	n/a	n/a
Other Long-Term Assets	454K	151K	14K	n/a	144K
Receivables	225K	n/a	n/a	109K	30K
Inventory	n/a	n/a	n/a	n/a	n/a
Other Current Assets	2.87M	2.72M	4.42M	543K	1.14M
Total Current Assets	246.62M	180.33M	198.66M	44.43M	7.18M
Property-Plant & Equipment	503K	270K	36K	n/a	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	n/a
Total Long-Term Assets	63.51M	16.26M	31.67M	n/a	144K
Total Assets	310.13M	196.59M	230.33M	44.43M	7.32M
Account Payables	1.38M	1.64M	1.09M	531K	223K
Deferred Revenue	n/a	n/a	n/a	n/a	n/a
Short-Term Debt	1.73M	210K	n/a	n/a	n/a
Other Current Liabilities	9.86M	5.96M	4.06M	5.84M	1.12M
Total Current Liabilities	12.97M	7.81M	5.15M	6.37M	1.34M
Long-Term Debt	27.62M	n/a	n/a	n/a	n/a
Other Long-Term Liabilities	2.56M	n/a	n/a	56.65M	17.4M
Total Long-Term Liabilities	30.18M	n/a	n/a	56.65M	17.4M
Total Liabilities	43.15M	7.81M	5.15M	63.02M	18.74M
Total Debt	28.49M	105K	n/a	n/a	n/a
Common Stock	6K	4K	4K	n/a	n/a
Retained Earnings	-222.8M	-170.43M	-127.57M	-26.96M	-19.64M
Comprehensive Income	312K	-751K	-231K	n/a	n/a
Shareholders Equity	266.97M	188.78M	225.18M	-18.59M	-11.42M
Total Investments	239.19M	63.34M	103.69M	n/a	n/a